Quantcast
Last updated on April 16, 2014 at 14:42 EDT

Latest Ascites Stories

2014-01-16 23:24:20

Researchers recommend that drug choice be guided by aspects of the patient’s condition. Raleigh, NC (PRWEB) January 16, 2014 Surviving Mesothelioma is reporting on newly published research suggesting that certain aspects of a peritoneal mesothelioma patient’s condition may have an impact on the toxicity of chemotherapy. A combination of pemetrexed (Alimta) and a platinum-based drug like cisplatin or carboplatin is the drug treatment of choice for patients with pleural mesothelioma,...

2013-12-09 10:03:31

Novel device able to isolate, analyze cancer cells from usually discarded abdominal fluid A microchip-based device developed by Massachusetts General Hospital (MGH) investigators may greatly simplify the monitoring of patients' response to treatment for ovarian cancer – the most lethal form of gynecologic cancer – and certain other malignancies. The team from the MGH Cancer Center and the Center for Systems Biology reports using their device to isolate and identify tumor cells from...

2013-10-04 23:23:03

Could the supplement quercetin eventually be used to improve the effectiveness of peritoneal mesothelioma treatment? A new study in mice suggests that it might. Raleigh, NC (PRWEB) October 04, 2013 A new animal study conducted in Croatia and detailed on Surviving Mesothelioma appears to show that the flavonoid quercetin, found in fruits, vegetables and grains, may make the heated chemotherapy treatment known as HIPEC more effective while protecting healthy cells against toxicity. HIPEC...

2013-01-21 08:24:55

KING OF PRUSSIA, Pa., Jan. 21, 2013 /PRNewswire/ -- Treatment with albumin reduces renal impairment and mortality in cirrhotic patients with spontaneous bacterial peritonitis (SBP), one of the most common bacterial infections in this patient population, according to a new meta-analysis supported by CSL Behring and published today in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association Institute. Albumin, a natural...

2012-10-30 07:26:44

ZÃœRICH, Switzerland, October 30, 2012 /PRNewswire/ -- Sequana Medical is pleased to announce that it has received CE mark approval for use of its alfapump(R) system in patients with ascites caused by cancer (malignant ascites). The alfapump(R) system was first introduced to the European market last year for patients with refractory ascites caused by advanced liver disease. The system is fully implantable, and automatically and continually collects ascites from the...

2012-04-27 23:00:49

The Gastroenterology and Healthcare Sciences are two new key health categories covered by the Sciences Social Network ScienceIndex.com. The users of the website monitor over 200 scientific Gastroenterology and Healthcare Sciences journals and submit the most significant scientific results of these journals for inclusion in ScienceIndex.com. ScienceIndex.com was established in 1998 to index the very latest news, headlines, references and resources from science journals, books and websites...

2012-03-28 10:22:59

KING OF PRUSSIA, Pa., March 28, 2012 /PRNewswire/ -- Administration of albumin reduces morbidity and mortality in cirrhotic patients undergoing large-volume paracentesis due to severe ascites, according to a new meta-analysis published online today in Hepatology, the official journal of the American Association for the Study of Liver Diseases. Compared with alternative treatments, albumin, a natural plasma-derived protein that expands blood plasma volume, significantly reduced the circulatory...

2012-03-01 00:00:00

ZÃœRICH, March 1, 2012 /PRNewswire/ -- NUB Grants Approval for Fifteen Leading Hepatology Centres in Germany. Sequana Medical announced today that its ALFApump(R) System has received German Neue Untersuchungs und Behandlungsmethode (NUB) approval which allows participating hospitals to receive reimbursement for innovative new products. Sequana Medical's ALFApump System is a fully implantable pump system designed to remove excess abdominal fluid, known as...

2011-12-09 00:00:00

ZURICH, December 9, 2011 /PRNewswire/ -- NHS National Innovation Centre supports the cost effectiveness of Sequana Medical's ALFApump System Sequana Medical announced today the findings of an independent economic assessment of the ALFApump System commissioned by the National Innovation Centre, the NHS organization which supports innovators, commissioners, and clinicians to speed up the development and use of innovations that will benefit the NHS. Brian Winn, Head...

2011-11-04 05:38:00

ZURICH, Switzerland, November 4, 2011 /PRNewswire/ -- Major milestone achieved in the commercial launch of new technology in the treatment of patients with refractory ascites due to liver cirrhosis. Sequana Medical, the Medical University of Vienna and Vienna General Hospital (AKH Wien) reported that the first two commercial implants worldwide of the ALFApump System were performed at Vienna General Hospital in October, under the supervision of Univ. Prof. Dr. Markus...